Scientists are reporting promising results in the early stages of a clinical trial designed to gage the feasibility of a
Continue reading »
mypharmacynews.com
Home »
Scientists are reporting promising results in the early stages of a clinical trial designed to gage the feasibility of a
Continue reading »Scientists have genetically engineered immune cells, called myeloid cells, to precisely deliver an anticancer signal to organs where cancer may
Continue reading »While rare, botulism can cause paralysis and is potentially fatal. It is caused by nerve-damaging toxins produced by Clostridium botulinum—the
Continue reading »Working in a highly successful collaboration between the Centre for Cancer Biology (a University of South Australia and SA Pathology
Continue reading »Wrapping an anticancer drug in a nanoscale case made of a polymer and a component of green tea is an
Continue reading »